References
- Merkel PA, Herlyn K, Martin RW, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheumatol. 2002;46(9):2410–2420.
- Matucci-Cerinic M KB, Wigley F. Evidence that systemic sclerosis is a vascular disease. Arthritis Rheumatol. 2013;65:1953–1962.
- Wigley FM, Flavahan N. Raynaud’s phenomenon. N Engl J Med. 2016;375(6):556–565.
- Park JK, Fava A, Carrino J, Del Grande F, Rosen A, Boin F. Association of acroosteolysis with enhanced osteoclastogenesis and higher blood levels of vascular endothelial growth factor in systemic sclerosis. Arthritis Rheumatol. 2016;68(1):201–209.
- Cappelli L, Wigley FM. Management of Raynaud phenomenon and digital ulcers in scleroderma. Rheum Dis Clin North Am. 2015;41(3):419–438.
- Amanzi L, Braschi F, Fiori G, et al. Digital ulcers in scleroderma: Staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatol (Oxford). 2010;49(7):1374–1382.